MedTrace Logo

Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia

NCT06611020 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2024-09-26

No results posted yet for this study

Summary

HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions

Conditions

  • Cervical Intraepithelial Neoplasia

Sponsors & Collaborators

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

    lead OTHER

Principal Investigators

  • Grazia Casadei, MD · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2025-01-31
Completion
2027-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06611020 on ClinicalTrials.gov